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Abstract
Background: The purpose of this study is to explore medication-related perceptions of adult patients with type 2
diabetes attending treatment in public hospitals of urban centers in central Ethiopia.
Methods: Qualitative in-depth interviews were held with 39 participants selected to represent a range of treatment
experiences and socio-demographic characteristics who were attending their treatment in 3 public hospitals. Interviews
continued until key themes were saturated. The interview and analysis was guided by Horne’s necessity-concerns model.
Results: The findings revealed medication-related perceptions some of which were similar to those of Western patients
and others that seem to be informed by local socio-cultural contexts. Participants’ perceptions focused on the necessity
of and concerns about their anti-diabetic medications, giving more emphasis to the latter. Concerns were expressed
about both perceived and experienced adverse effects, inconveniences in handling the medications and access. It was
evident that some of these concerns were exaggerated but could nevertheless negatively affect adherence to
prescribed medications including resistance to initiate insulin with potential impact on health outcomes.
Conclusions: Understanding patients’ perceptions of their medications is critical for developing a diabetes education
program that considers local contexts and beliefs to enhance adherence. Education programs should consider patients’
concerns about medication adverse effects and reasons for use so as to improve their adherence and health outcomes.
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Background
Diabetes mellitus, especially type 2 (hereafter referred to
as diabetes) is increasingly becoming an important pub-
lic health problem in sub-Saharan Africa including
Ethiopia with a prevalence estimate of 5.1%, and higher
rates reported from the urban centers [1–4]. Ethiopian
studies indicate that the majority of patients have poor
health status including blood glucose levels well above
recommended levels with a high proportion also having
experienced micro- and macro-vascular diabetes-related
complications [5–9]. One of the studies also reported
uncontrolled diabetes leading to hospital admissions in a
high proportion of surveyed patients [6]. A similar study
reported that direct hospital costs for patients with
diabetes was significantly higher compared to controls
and that substantial a part of the cost was related to
treatment for diabetes-related complications [10].
Among the mainstay of diabetes therapy are the anti-
diabetic agents which greatly contribute to the control
of blood glucose levels and associated micro- and
macrovascular complications. The success of these
agents, and other components of the treatment regimen,
depends among other things on patients’ adherence to
their recommended regimen so as to prevent acute com-
plications and reduce long term complications [11].
However, adherence to medication regimens has been
found to be a major challenge for patients with diabetes.
Lower adherence to recommended medication regimens
has been reported to have a negative impact on health
outcomes and health services utilization such as emer-
gency department visits, hospitalization and doctors’
visits [12].
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The review paper by Capoccia et al. (2016) found that
lower medication adherence was related to concerns
about medication side effects and doubts about their
necessity. This study also highlighted the influence of
cultural variations in medication-related beliefs among
different ethnic groups on adherence. These findings
and others suggest the need for patient-centered ap-
proaches that consider patient preferences and address
their specific medication-related concerns [12]. A num-
ber of approaches to improve adherence to anti-diabetic
medications are reported including educational and
pharmacy-driven interventions [11, 13, 14]. The most
effective approaches appear to be those that provide
proactive care, and where visits are coordinated among a
team of healthcare providers, in either community or
institutional settings. Furthermore, interventions should be
based on the principles of patient-centered care that re-
quire patients’ active involvement in their self-management
[11, 15]. The different interventions are based on studies of
medication adherence to diabetes and influencing factors
that have mostly been conducted in Western nations or
minority groups living in Western countries. There is a
dearth of literature from developing countries like Ethiopia
which are facing an increasing burden from diabetes.
Among the widely reported conceptual models to
assess patients’ medication related perceptions is the
necessity-concerns framework which posits that patients’
treatment perceptions, especially those with respect to
beliefs about necessity and concerns, will play an influ-
ential role when patients come face to face with deci-
sions to take medications [16, 17]. Patients’ perceptions
are likely different from that of their healthcare pro-
viders, and are thought to be based on their perceptions
of the evidence about the benefits and risks [18].
The ‘necessity’ part of the Necessity-Concerns frame-
work deals with the perceptions of personal need that
patients may have for the medicines which may also be
influenced by their beliefs about the efficacy of the medi-
cines [16, 17]. The ‘concerns’ part deals with both con-
crete and abstract concerns related to medication-taking.
The concrete experiences have to do with unpleasant
symptoms such as side-effects and disruptions of daily
life, while abstract concerns have to do with worries that
regular use could lead to dependence or long term
effects [16, 17]. In cases when the perceived necessity is
strong and the perceived concerns are weak, patients
tend to follow recommendations to adhere while strong
perceived concerns and weaker necessity may lead to
them not to adhere to treatments. Treatment perceptions
may also lead to unintentional non-adherence if, for
instance, patients who consider their medicine to be
unimportant for their condition forget to take it. Apart
from necessity and concerns perceptions, culture has also
been reported to influence adherence to medications. It is
also noteworthy that patients may not adhere due to
reasons related to unintentional non-adherence(i.e., due to
lack of resources) [17].
There are a limited number of articles focusing on
adherence to anti-diabetic treatment in developing coun-
tries like Ethiopia. The few studies from Ethiopia report
unacceptably low levels of adherence to recommended
medications. The common factors cited for the low
levels of adherence include: being on non-insulin drug
regimen [19]; consulting traditional healers [19]; lack of
financial resources [20]; perceived side effects [20];
experience of depressive symptoms [21]; complexity of
medication regimens [21] and concerns about medica-
tions’ safety [22]. All of these were reported in quantitative
studies and provide limited insight into patients’ perspec-
tives of their medications which may be used to design
patient-centered interventions to encourage adherence.
The aim of this study was to conduct a theory-guided,
exploratory study using qualitative methods to elicit
medication-related beliefs of type 2 diabetes patients
who are following treatment in Addis Ababa (the largest
urban center of Ethiopia) and Butajira (a town in Central
Ethiopia that serves as center for the demographic
surveillance site of Addis Ababa University) [23]. The
Necessity-Concerns conceptual framework that has been
widely used to study chronic patients was selected as the
conceptual framework [17].
Methods
This study is part of a larger study that utlized qualitative
interview methods to gain in-depth understanding of
issues surrounding patients’ medication-related perpcep-
tions in urban Ethiopia. In-depth interviews with indi-
vidual participants were conducted from December 2013
to March 2014 in locations that were mutually agreed by
individual participants and the first author (BMH, a
licensed pharmacist and PhD student trained in qualitative
research methods) such as a quiet place in the hospital
compound, participants’ homes, church compound, quiet
spot in cafes, an academic office and a hospital office.
Ethical approval (036/13/PSP) was obtained from the
Institutional Review Board of the College of Health
Sciences, Addis Ababa University.
Study setting
Participants were selected from three public hospitals in
central Ethiopia. Two of these, Tikur Anbessa Specialized
Hospital (hereafter referred to as Tikur Anbessa) and
Yekatit 12 Medical College Hospital (hereafter referred to
as Yekatit 12) are located in Addis Ababa and serve a high
number of patients with type 2 diabetes. The third hos-
pital, Butajira General Hospital (hereafter referred to as
Butajira) located in Butajira town located 135 kms away
from Addis Ababa is the only public hospital in this town
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and was included to explore the perspectives of patients in
a peri-urban area of central Ethiopia. Table 1 gives a brief
description of the two settings.
Tikur Anbessa is currently the highest referral hospital
in Ethiopia. During the study period, patients were seen in
the Endocrinology Unit that was run by 3 endocrinologists
and 2 endocrinology fellows working as consultants on a
rotating basis, up to 6 Internal Medicine residents who
were assigned to take primary roles in managing patients
during their month-long attachments, 6 nurses and 1
recently recruited pharmacist.
Yekatit 12 is a general hospital that has recently started
training doctors. The services provided for patients with
diabetes were mostly in the general outpatient department
(with no dedicated or separate diabetes care clinic) that
was run by 4 general practitioners with complex cases re-
ferred to the medical referral clinic, run by internists on a
rotating basis. In both of the above hospitals, patients
would be ‘randomly’ assigned to a physician each time
they come for their appointment.
Butajira, also a general hospital, serves patients with
diabetes at a medical clinic separate from other outpa-
tients. The clinic was run by a general practitioner and a
nurse where patients meet the same physician and nurse
each time they come for their monthly appointments for
at least a 6-month period.
Study participants recruitment
Patients with diabetes who were attending treatment in
the selected hospitals during the study period who were
18 years and older, had been prescribed anti-diabetic med-
ications for minimum of one year and had no known or
overt psychiatric problems were eligible to participate. Be-
ing a healthcare professional was the only exclusion criter-
ion. Participants were purposively selected to include a
wide variety of patients in terms of socio-demographic
characteristics (age, sex, educational level, marital status,
employment status, religious affiliations and place of resi-
dence), income level, medication regimen and years since
diagnosis. Participant recruitment was facilitated by the
clinic nurses who identified the patients and provided ini-
tial information about the study which was followed up by
the first author who provided further information and re-
cruited eligible patients.
Interview methods
Interviews were conducted in the Amharic language
which is the official and widely used language in the
study settings. The first author conducted the interviews
(audio recorded with partcipants’consent) that ranged
from 30 to 120 min. Sets of questions recommended by
Kleinman et al. (1978) [24] and those from the
necessity-concerns framework [16] were used to frame
the interview guide (Appendix). Study participants were
asked to discuss their treatment perceptions including
their views on the necessity and concerns about their
medication regimen. The interview guide was translated
to Amharic and back to English to check the consistency
before using the Amharic version.
Data analysis
The interviews were transcribed verbatim into MS Word
by an experienced assistant. The quality of the tran-
scripts was checked by the first author by listening to
randomly selected recordings from each study site while
reading transcripts. Transcripts were read repeatedly to
ensure good understanding before coding them to iden-
tify components of the necessity-concerns framework.
Coding included looking for new themes emerging from
the data that were unique. Interviews continued until all
key themes were saturated (the point at which no new
information was emerging) [25]. Analysis and interpret-
ation was carried out by the first author in collaboration
with the last author. Initial coding and categorization
was done in Amharic followed by further analysis and
interpretation which was done after translating key com-
ponents relevant to the emerging themes into English.
NVivo 10 was used to manage the data.
Results
Description of the study participants
Forty-five patients who met the eligibility criteria were
identified during the study period of which 6 did not
participate either due to personal reasons or because of
Table 1 Description of study settings
Addis Ababa Butajira
Significance Largest urban center in Ethiopia Home to the demographic surveillance site of AAU
Population [48] 3.2 million 63 thousand
Ethnic groups [49] Amhara (47%), Gamo (1.7%), Guragie (16.3%), Oromo (19.5%),
Silte (2.9%), Tigrie (6.2%), others (6.4%)
Guragie (82%), others (18%)
Religions [49] Orthodox Christianity (74.7%), Islam (16.2%), Protestant
Christianity (7.8%), others (1.3%)
Islam (51.3%), Orthodox Christianity (39.6%) and Protestant
Christianity (8.7%), others (0.4%)
Literacy [49] 85.3% 37.9%
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problems with telephone communication. Of the 39
patients with diabetes who participated in the study, 24
were residents of Addis Ababa following treatment at
Tikur Anbessa and Yekatit 12 and the remaining of
Butajira town or its environs. Table 2 summarizes
demographic characteristics of the study participants. As
notable differences were not observed in the perceptions
of participants from the different sites, the data are pre-
sented as a single set.
Treatment perceptions
The findings revealed that most study participants didn’t
know the names of their anti-diabetes medicines and in-
stead labeled them using the Amharic terms for pill
(kinin) and injection (merfe). Among the pills glibencla-
mide (a sulfonylurea), was labelled as the small or the
thin one, while metformin (a biguanide), was the bigger
or fatter one. A few, with better education, used brand
names such as Daonil (a popular trade name for glibencla-
mide even if most actually took the generic versions), or
Metformin. Participants’ treatment perceptions focused
primarily on the necessity and concerns although it was
apparent that increased emphasis was given to the con-
cerns aspects of the medications and less to their necessity.
With regards to necessity perceptions towards anti-
diabetic medications, they were mostly related to the
health benefits and their efficacy. Generally, perceptions
of necessity were stronger, with respect to insulin than
for oral hypoglycemic agents:
Now, if you stop your medicines [the pills] it could bring
problems, may make you lose your eye (sight), paralyzed.
(Male, 61 years, elementary school complete)
And so when it wouldn't go down (with the tablets), they
changed it to the injection …. And it's done well, I now
started to feel good inside. There is no weakness that
used to be there, none of that … (Female, 60 years, high
school complete)
Participants’ concerns with regards to their anti-
diabetic medications can be broadly categorized into: a)
perceived concerns about the efficacy of the oral anti-
diabetic agents; b) abstract concerns/worries of adverse
effects; c) the actual experience of adverse effects; d)
challenges with use and storage and; e) challenges with
medicines availability or affordability.
Concerns about the efficacy of oral anti-diabetic agents
The efficacy of the generic oral anti-diabetic medications
available through the hospital pharmacy either for free
or at low prices were questioned mostly in relation to
their perceived lesser efficacy compared to the western
brand medicines.
The Indian ones (tablets) are useless and if the
government tried to import the German ones, now
that could be helpful for the patients; otherwise these
are useless. But what other choice do we have? …
(Male, 54 years, high school complete)
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Glimepiride + metformin 1
Glibenclamide 1
Insulin 14
Insulin plus metformin 1
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Worries about potential adverse effects of the
anti-diabetic medicines
Worries were expressed about possible adverse effects of
anti-diabetic medicines with hypoglycemia and gastritis
cited as common concerns and as well about ‘too many’
medicines to a lesser extent. There were cases however
where certain diabetes complications such as impotence
and eye damage were attributed to be adverse effects of the
medications on the one hand and the hypoglycemia due to
the medications was ascribed to diabetes on the other.
They say that it (diabetes) makes you fall and that
you should always have candy or sugar on you. But
how can I take sugar when I have been prohibited. My
sugar has gone up and I have been told not to eat
sweets and so how can I carry with me sugar?
(Male, 61 years, elementary school complete)
I hear from professionals with whom I work that the
medicine has many side-effects; the Daonil creates
problems on the eye, metformin damages the
stomach. … Yes it (the medicine) has many side-effects.
(Male, 46 years, Diploma holder)
Insulin was associated with a higher degree of severity
because patients believed it was prescribed when the dia-
betes was not responding to other forms of treatment.
This was perceived as evidence that one has perhaps
neared the end of life and thus some patients became very
emotional when discussing new insulin prescriptions:
The very idea of injection disturbs one emotionally. It
is also disturbing when discussed by the community.
(Male, 46 years, Diploma holder)
Different adverse effects have been associated with in-
sulin such as falls, paralysis and weight gain. The expres-
sion of some had an emotional tinge to it revealing a
strong feeling against insulin. On the other hand, a par-
ticipant who earlier on had a serious concern which has
since been replaced with strong expressions about the
necessity of insulin was an interesting finding.
Injections need great care; if the (sugar) levels go down
there is the possibility of falling down and that’s what
I think of. I don't think I will be able to get up again
if I fall. I am hypertensive and such complications
may make me paralyzed. (Female, 55 years,
Diploma holder)
They said that I deserved injections after this (sugar
levels wouldn’t go down with the tablets)… I was very
startled (when they told me to start on injections). I
didn't think I would be able to stand and walk. I was
so fearful…. (But) it is only after the injections that
I regained my identity and I became happy.
(Female, 65 years, low education status)
The influence of others, be it positive or negative, on
insulin initiation was also reported. The positive aspects
which participants observed or heard seem to have
allayed some of their concerns while the negative aspects
such as observing the scars and suffering apparently
have negative influences towards initiating insulin.
I hate it [insulin]. Even when I got diabetes I hoped
not to become an insulin user. I don't know why. I
sadden when I see her (my sister's) body. When I see
her I don't feel as if I am ill. I just see her suffering.
The places in her body which have been injected have
scarred so much and created a pattern on its own….
and her body is like a sieve. (Male, 45 years, high
school complete)
Experience of adverse effects
Study participants described their experiences of adverse
effects they perceived as being associated with their oral
anti-diabetic agents and insulin. The most common adverse
effects associated with oral anti-diabetic agents were gastri-
tis. In addition, some taking glibenclamide reported hypo-
glycemic feelings such as feeling dizzy and shivering.
Hypoglycemia was a major concern for those on insu-
lin where shivering, dizziness, loss of consciousness and
falls were reported. It was evident that the hypoglycemic
incidents were puzzling, and led to emotional reactions
for some of the study participants:
My problem now is my fainting, it disturbs me. I say
what if it (the fainting) happens while travelling on the
road. Who would pick me up? Then my mother would
no more have a child and my daughter wouldn't have
a mother. That possible scenario disturbs me a lot.
(Female, 46 years, high school complete)
The hypoglycemic incidents above have led to life-
threatening incidents and hospital emergency admissions
for some study participants while it has led to extended
treatment and absences from work for others.
Fear of pain associated with injections, which may
directly impact adherence, was also identified by study
participants as a concerning side effect.
The injection indeed is difficult. I used to shiver and in
the process hurt my legs. I had started injections one
time. And so it was very painful and I also told myself
of its painfulness. I imagined not about the efficacy of
the medicine but of the bruise marks that it will leave
on my body. (Female, 37 years, high school complete)
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Challenges with use and storage
Perceptions about the need for stricter adherence re-
quired of insulin were cited as reasons to resist recom-
mendations to start this medication:
I didn't want the injection because they told me that
you couldn't discontinue it from time to time (as is
possible for the pills in case one has to go for holy
water). (Male, 68 years, low education status)
I think the injection is a bit complicated as compared
to ours especially with regards to time. Now we can
take our medicines (pills) but can stay for 2 or even
3 h without eating but they would fall. If they say 8
o'clock, they have to take it exactly at 8 o'clock.
(Male, 63 years, high school complete)
The inconvenience of handling insulin especially in re-
lation to its cold storage requirement was mentioned to
restrict mobility:
I find the injection to be very difficult because I am
used to the tablet… It is more convenient (to transport
and store even in rural areas). The injection needs a
fridge and when you go out it is difficult (to use it)
because if it is not placed in the fridge it will be
damaged. And so if I go to my relatives who live far
away, I could take my medicines in my pocket.
(Male, 54 years, high school complete)
Challenges with the availability and affordability of the
medicines
Concerns were expressed by some in relation to the avail-
ability and affordability of the prescribed medicines. For
some, the concern is related to having to pay for the medi-
cines as it was not affordable for them even to buy from
the hospital pharmacy where generic medicines were
available at low prices. For others it was the unavailability
in the hospital pharmacy which might lead to paying even
higher prices in the private outlets, or worse, having to
buy low quality products from illegal sources.
There are some people who inject expired medicines
after buying it from private sources… Now if the
medicine is not available at the hospital you have to
buy it from outside. One time a friend of mine was
offered to buy such medicine by some people who just
rolled it up in a plastic bag and he encountered a
problem. Now many people face such problems.
(Male, 57 years, elementary school complete)
Yes sometimes medicines are unavailable (at the
hospital). Now last time they were unavailable and we
had to buy at the pharmacy (private). When one is
available the other is not. There is a problem with
medicines. (Male, 54 years, high school complete)
Discussion
This qualitative study of patient perceptions of anti-
diabetic medications is a first from Ethiopia. Many par-
ticipants perceived the medications’ necessity, with
stronger belief in the efficacy of insulin compared to the
oral agents. Given the increased emphasis on concerns
about medications compared to their necessity, it is
quite likely that these perceptions impact adherence to
prescribed regimens and recommendations to initiate in-
sulin. This seems to be in line with the necessity-
concerns framework proposed by Horne et al. (2003)
where such perceptions about necessity and concerns
can lead to intentional non-adherence [16].
A range of concerns about the potential adverse effects
of the oral agents were raised. These include concerns
which were similar to those raised by Western patients
that were mainly about adverse effects (e.g. hypoglycemia
and gastritis) and to a lesser extent the number of medi-
cines being taken [26, 27]. Medications-related concerns
which are specific to this study include perceived adverse
effects which are actually expected as complications of
diabetes itself (e.g., impotence and eye problems) or relat-
ing hypoglycemia to the illness itself as a complication
and not to the medication as adverse effects as also
reported by another local quantitative study [28]. This sig-
nifies about the need to be open in assessing patient per-
ceptions so that appropriate education about the diabetes
and the drugs used to treat it may be offered. Such mea-
sures could minimize safety concerns which is one of the
major barriers reported by local studies that have been re-
ported to affect adherence to medications [20–22].
This study revealed hypoglycemia to be a major con-
cern among some study participants on oral agents.
Hypoglycemic incidents which included falls that were
encountered personally or among their social circles
could expectedly make patients to skip doses or make
them reluctant to accept dose increments or additional
medication. As most study participants were taking glib-
enclamide, the reported hypoglycemia, is not unexpected
given its high hypoglycemic potential [29, 30]. The find-
ings from a study done in Nigeria similarly reported
hypoglycemia as one of the most common side effects
and common reasons for non-adherence for those pa-
tients on glibenclamide [31]. Glibenclamide has further
been associated with cardiac risks where one study re-
ported how the initial treatment with glibenclamide was
associated with a more than two-fold increase in the risk
of coronary artery disease which was however reduced
with newer sulphonylureas such as glimepiride and gli-
clazide [32]. The findings of the present study and sup-
porting literature further highlight about the need by the
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government to consider alternative generic oral anti-
diabetic agents available with comparable costs but less
hypoglycemic potential such as glimepiride, another
member of the sulfonylurea family [29].
There were others who expressed concern about per-
ceived inefficacy of the generic oral anti-diabetic agents
that were made available to patients for free or at low
prices. Such type of concern about generic medicines is
reported in another study conducted among patients at-
tending treatment for diabetes in selected public and
private health facilities in Addis Ababa. This study re-
vealed that only 30% were comfortable taking any brand
even if their physician recommended it and quality was
one of their main concerns [33]. The concern towards
generic medicines do not seem to be limited to the pa-
tients but also extends to the providers. For example a
study reported that over one-third of community phar-
macy clients and pharmacy personnel apparently had
distrust on the approval system for generic medicines in
Ethiopia [34]. This issue needs the attention of policy
makers and healthcare providers to provide relevant
education about generic medicines as such concerns
may affect adherence [35].
On the other hand findings of a local study that evalu-
ated the quality of different brands of amoxicillin cap-
sules marketed in Ethiopia showed that most generic
brands were not interchangeable with the innovator
brand. A recommendation was made by that study for
the reinforcement of the capacity of the drug regulatory
body including strengthening of post marketing studies
[36]. Another post marketing study done to assess
quality of antibiotic, antimalarial and anti-tuberculosis
medicines from selected sites in Asia, Africa (including
Ethiopia) and South America reported that 848 (5.6%) of
the total samples failed the quality test and furthermore
81 counterfeit medicines were reported, 13.6% of which
were from Africa [37]. This highlights for the need to
work to strengthen the regulatory system and ensure the
quality of medicines at all levels of the supply chain so
that efforts to increase access to affordable, generic med-
icines and improve the health outcomes of patients
achieve intended outcomes.
With regards to insulin initiation, most of the con-
cerns are similar to those reported elsewhere including
insulin signifying an increased degree of illness severity
and adverse effects mainly hypoglycemia [38]. Among
the concerns that may be unique to this study is the per-
ceived need for stricter adherence required with insulin
compared to the oral agents which is perceived to be
complicated by local religious healing practices such as
use of holy water [39]. The use of holy water has been
reported to lead to discontinuation of treatment accord-
ing to studies done on other chronic illnesses [40, 41].
This issue needs to be assessed in a nonjudgmental
approach. Patients need to be educated about the benefits
of following recommended regimens and not discontinu-
ing their treatment even if they intend to use holy water.
Such attempts actually may need the support of higher
level policy interventions as has been tried for HIV/AIDS
treatment. In this regard collaborative work with religious
leaders has endorsed the combined use of anti-HIV medi-
cations and holy water as compatible, encouraging the use
of both types of treatment and contributed to increase in
adherence to recommended regimens [40].
The issue of perception that insulin needs to be refriger-
ated at all times appears to be another potential problem
in relation to its initiation as many may not possess refrig-
erators. If they are living in the rural areas or are to travel
outside urban centers, accessing cold storage may be even
more difficult [42]. Such conditions could thus be consid-
ered as credible reasons to resist recommendations to ini-
tiate insulin regimen by the patients. Healthcare providers
should take time to assess their patients’ perceptions and
contexts to discuss as needed about the importance of
cold storage conditions for insulin, its utility for short and
long term conditions and possible options to store espe-
cially for the spare insulin vials such as with relatives,
friends or others who have a fridge. They should also
stress the acceptability of storing insulin that is being used
at room temperatures and that it should not impede ac-
ceptance of an insulin regimen [42–45].
It was also apparent from this study that some of those
who expressed concerns about insulin were willing to
accept an insulin regimen if it were recommended by
their healthcare providers. This should be given due
consideration in light of the reluctance to prescribe it by
some providers citing strong patient resistance [38, 46].
Group diabetes education programs should be strength-
ened. Patients who have started on insulin and demon-
strated improved health outcomes may have passed
through the same anxiety as those patients who have con-
cerns and so may play beneficial roles in such programs.
The utility of other patients who are more experienced
and ‘further along the treatment trajectory’ has been cited
in reassuring patients who may be anxious about starting
new treatments such as insulin [47]. It has to be stressed
however that while group education may play a critical
role in the care program of patients, they should not be a
substitute for one to one education of patients by
appropriately trained healthcare providers. Such individual-
based educations would allow assessment of patients’
knowledge, beliefs and requisite skills with respect to their
medications and facilitate a more tailored and patient-cen-
tered approach in educating and discussion to alleviate
their concerns and improve their medication-taking
behavior.
This study explored the perceptions of limited groups of
patients with diabetes – those following their treatment at
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a public hospital in urban settings and consented to par-
ticipate –and may not be representative of a larger and
more diverse population. The findings may not be applic-
able to those who may have avoided biomedical treatment
and also those attending treatment in the private health
institutions who may be of higher socio-economic stand-
ing. This study however recruited patients of diverse
socio-demographic backgrounds and having varied dur-
ation of illness which has allowed a rich and diverse infor-
mation on their perceptions about anti-diabetic medicines
which gave us a good insight. This study also gave the
context for the majority of patients with diabetes who at-
tend treatment in these urban centers which can be trans-
lated to other hospitals and patients with similar settings.
Conclusions
Findings of this study are suggestive of the utility of
the necessity-concerns framework in organizing the
medication-related perceptions in our setting. While some
of the participants’ anti-diabetic medications-related per-
ceptions appeared to be similar to those expressed by
Western patients, there were perceptions that were
different including the exaggerated concerns towards oral
agents and insulin which could potentially lead to
intentional non-adherence and affect health outcomes.
Diabetes education, be it individual or in groups, needs to
consider local contexts such as patients’ religious back-
grounds and their socio-economic contexts in addressing
about the use of holy water, medication adverse effects
and insulin storage among other things.
Appendix
Interview guide
1. What treatment has been recommended to you by
your healthcare provider(s)?
2. What are the most important results you hope to
receive from this treatment?
3. What is your view regarding the necessity of the
treatment regimen(s) recommended by your
healthcare provider?
4. What are your concerns in relation to the anti-diabetic
medications that are recommended by your healthcare
provider?
5. If there is any other thing you would like to add in
relation to our discussion on medications that have
been recommended for your diabetes?
Acknowledgements
The authors would like to acknowledge the patients who actively
participated in this study and the healthcare providers who facilitated the
study. The contribution of Berhanu Abera for the laborious transcription
process is also highly acknowledged. Finally, the constructive comments and
suggestions given by the anonymous reviewers is highly appreciated.
Funding
Funding for the PhD study of the first author and this project was obtained
from Addis Ababa University. The University had no undue influence in the
design, conduct or reporting of the study.
Availability of data and materials
Data which are the audio recordings and transcripts of interviews will not
be shared at this time. The interviews which were conducted in Amharic
(the official and widely used language of Ethiopia) may be of limited use
to international readers. Furthermore, there is the possibility of losing
anonymity if interview transcripts were made available as some may contain
identity revealing information. However these data sets may be available
from the corresponding author upon reasonable request.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
BMH, TGF and HB author were involved in the conceptualization and the
design of the study. BMH carried out the interviews. BMH and HB were
involved in the analysis of the interviews with TK and TGF commenting on
their analysis. BMH drafted the manuscript and all the others revised it. All
authors read and approved the final manuscript.
Ethics approval and consent to participate
All the participants in this study were provided with adequate information
about the study (including that some of their verbatim expressions may be
published) and their participation before they gave their consent. The study
received ethical approval from the Institutional Review Board of the College of
Health Sciences, Addis Ababa University (protocol number 036/13/PSP).
Furthermore, the study was approved by the heads of the respective hospitals.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1School of Pharmacy, College of Health Sciences (CHS), Addis Ababa
University (AAU), Addis Ababa, Ethiopia. 2School of Medicine, CHS, AAU,
Addis Ababa, Ethiopia. 3Leslie Dan Faculty of Pharmacy, University of
Toronto, Toronto, Canada.
Received: 21 July 2016 Accepted: 21 March 2017
References
1. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa
1999-2011: Epidemiology and public health implications. a systematic
review. BMC Public Health. 2011;11:564.
2. IDF, IDF Diabetes Atlas 2014 Update. 6th edition. 2014.
3. Yemane T, Belachew T, Asaminew B, Befekadu O. Type II diabetes mellitus
in Jimma Town, Southwest Ethiopia. Ethiop J Heal Sci. 2007;17:107–114.
4. Abebe SM, Berhane Y, Worku A, Assefa A. Diabetes mellitus in North West
Ethiopia: a community based study. BMC Public Health. 2014;14:1–18.
5. Adem A, Demis T, Feleke Y. Trend of diabetic admissions in Tikur Anbessa
and St. Paul’s University Teaching Hospitals from January 2005-December
2009, Addis Ababa, Ethiopia. Ethiop Med J. 2011;49:231–8.
6. Feleke Y, Enquselassie F. An assessment of the health care system for
diabetes in Addis Ababa, Ethiopia. Ethiop J Heal Dev. 2005;19:203–10.
7. Gudina EK, Amade ST, Tesfamichael FA, Ram R. Assessment of quality of
care given to diabetic patients at Jimma University Specialized Hospital
diabetes follow-up clinic, Jimma, Ethiopia. BMC Endocr Disord. 2011;11:19.
8. Nigatu T. Epidemiology, complications and management of diabetes in
Ethiopia: A systematic review. J Diabetes. 2012;4:174–80.
9. Worku D, Hamza L, Woldemichael K. Patterns of diabetic complications at
Jimma University. Ethiop J Heal Sci. 2010;20:33–9.
10. Feleke Y, Enquselassie F. Cost of hospitalization of diabetic patients
admitted at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Ethiop Med J. 2007;45:275–82.
11. American Diabetes Association. Standards of Medical Care in Diabetes - 2017.
Diab Care. 2017;40(Suppl 1).
Habte et al. Journal of Pharmaceutical Policy and Practice  (2017) 10:14 Page 8 of 9
12. Capoccia K, Odegard PS, Letassy N. Medication Adherence with Diabetes
Medication: A Systematic Review of the Literature. Diabetes Educ.
2016;42:34–71.
13. Sapkota S, Brien JAE, Greenfield JR, Aslani P. A systematic review of
interventions addressing adherence to anti-diabetic medications in
patients with type 2 diabetes - components of interventions. PLoS ONE.
2015;10(6):e0128581.
14. Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB,
Granger CB, Trygstad T, Liu LZ, Bosworth HB. Improving diabetes
medication adherence: Successful, scalable interventions. Patient Prefer
Adherence. 2015;9:139–49.
15. Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes
management in US primary care settings: a systematic review. Cdc.
2013;10:1–21.
16. Horne R. Treatment perceptions and self-regulation. In The Self-Regulation
of Health and Illness Behaviour. Edited by Cameron LD, Leventhal H. New
York: Routledge; 2003:138–153.
17. Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V.
Understanding Patients’ Adherence-Related Beliefs about Medicines
Prescribed for Long-Term Conditions : A Meta-Analytic Review of the
Necessity-Concerns Framework. PLoS ONE. 2013;8(12):e80633.
18. Horne R, Parham R, Driscoll R, Robinson A. Patient’s attitudes to medicines
and adherence to maintenance treatment in inflammatory bowel disease.
Inflamm Bowel Dis. 2009;15:837–44.
19. Abebe SM, Berhane Y, Worku A. Barriers to diabetes medication adherence
in North West Ethiopia. Springerplus. 2014;3:195.
20. Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes
mellitus and self management practices among type-2 diabetics in Ethiopia.
N Am J Med Sci. 2011;3:5–10.
21. Teklay G, Hussein J, Tesfaye D. Non-adherence and associated factors
among type 2 diabetic patients at Jimma University Specialized Hospital,
Southwest Ethiopia. J Med Sci. 2013;13:578–84.
22. Bizu G, Habte BM. Effect of medications-related beliefs on adherence to
treatment of type II diabetes mellitus in a primary healthcare setting,
Addis Ababa, Ethiopia. Int J Pharm Sci Res. 2016;7:144–52.
23. Shamebo D, Sandstrom A, Wall S. The Butajira rural health project in
Ethiopia: epidemiological surveillance for research and intervention in
primary health care. Scand J Prim Health Care. 1992;10:198–205.
24. Kleinman A, Eisenberg L, Good B. Clinical Lessons from Anthropologic and
Cross-Cultural Research. Ann Intern Med. 1978; 88 (2):251–258.
25. Creswell JW. Educational Research: Planning, Conducting, and Evaluating
Quantitative and Qualitative Research. 4th ed. Boston: Pearson; 2012.
26. Grant RW, Pabon-Nau L, Ross KM, Youatt EJ, Pandiscio JC, Park ER. Diabetes
Oral Medication Initiation and Intensification: Patient Views Compared to
Current Treatment Guidelines. Diabetes Educ. 2011;37:78–84.
27. Lawton J, Peel E, Parry O, Douglas M. Patients’ perceptions and experiences
of taking oral glucose-lowering agents: A longitudinal qualitative study.
Diabet Med. 2008;25:491–5.
28. Tassew B. Assessment of diabetes self-care practice and its associated
factors among patient on follow up at public and private primary level
health care in Addis Ababa. Ethiopia: Addis Ababa University; 2015.
29. Davis SN. Insulin, oral hypoglycemic agents and the pharmacology of the
endocrine pancreas. In Goodman & Gilman’s The Pharmacological Basis of
Therapeutics. 11th edition. Edited by Brunton LL. New York: McGraw-Hill; 2006.
30. Bolen S, Feldman L, Vassy J, Wilson L, Yeh H. Systematic Review:
Comparative Effectiveness and Safety of Oral Medications for Type 2
Diabetes Mellitus. Ann Intern Med. 2015;147:386–99.
31. Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and
self management practices among type-2 diabetics in Nigeria. Pharm World
Sci. 2008;30:876–83.
32. Sadikot SM, Mogensen CE. Risk of coronary artery disease associated with
initial sulphonylurea treatment of patients with type 2 diabetes: A matched
case-control study. Diabetes Res Clin Pract. 2008;82:391–5.
33. Regassa G. Assessment of treatment patterns in type 2 diabetes mellitus
and the perception of patients about oral antidiabetics in selected health
facilities in Addis Ababa. Addis Ababa University; 2008.
34. Sahile M. Knowledge, attitude and practice on generic medicine among
community pharmacy clients’ and pharmacy personnel in Hawassa, A
facility based cross sectional Study. Addis Ababa University; 2014.
35. Keenum AJ, DeVoe JE, Chisolm DJ, Wallace LS. Generic medications for you,
but brand-name medications for me. Res Soc Adm Pharm. 2012;8:574–8.
36. Kassaye L, Genete G. Evaluation and comparison of in-vitro dissolution
profiles for different brands of amoxicillin capsules. Afr Health Sci.
2013;13:369–75.
37. Hajjou M, Krech L, Lane-Barlow C, Roth L, Pribluda VS, Phanouvong S,
El-Hadri L, Evans III L, Raymond C, Yuan E, Siv L, Vuong TA, Boateng KP,
Okafor R, Chibwe KM, Lukulay PH. Monitoring the quality of medicines:
results from Africa, Asia, and South America. Am J Trop Med Hyg.
2015;92:68–74.
38. Ng CJ, Lai PSM, Lee YK, Azmi SA, Teo CH. Barriers and facilitators to starting
insulin in patients with type 2 diabetes: A systematic review. Int J Clin Pract.
2015;69:1050–70.
39. Kassaye KD, Amberbir A, Getachew B, Mussema Y. A historical overview of
traditional medicine practices and policy in Ethiopia. Ethiop J Heal Dev.
2006;20:127–34.
40. Kloos H, Hailemariam D, Kaba M, Tadele G. Traditional medicine and
HIV/AIDS in Ethiopia : Herbal medicine and faith healing: A review.
Ethiop J Heal Dev. 2013;27:141–55.
41. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM.
Barriers and facilitators of adherence to antiretroviral drug therapy and
retention in care among adult HIV-positive patients: a qualitative study from
Ethiopia. PLoS ONE. 2014;9:e97353.
42. Gurmu AE, Teni FS. Knowledge, attitude and practice among diabetic
patients on insulin therapy towards the disease and their medication at a
university hospital in Northwestern Ethiopia : a cross-sectional study.
Int J Pharma Sci Res. 2014;5:685–92.
43. Gill G, Price C, English P, Eriksson-Lee J. Traditional clay pots as storage
containers for insulin in hot climates. Trop Doct. 2002;32:237–8.
44. Puepet F, Mijinyawa B, Akogu I. Insulin storage by patients with diabetes
mellitus in Jos, Nigeria. J Med Trop. 2007;9:37–40.
45. Gill GV. Stability of insulin in tropical countries. Trop Med Int Heal.
2000;5:666–7.
46. Haque M, Emerson SH, Dennison CR, Navsa M, Levitt NS. Barriers to initiating
insulin therapy in patients with type 2 diabetes mellitus in public-sector
primary health care centres in Cape Town. S Afr Med J. 2005;95:798–802.
47. Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-
regulation of health and illness. In The Self-Regulation of Health and Illness
Behaviour. First. Edited by Cameron LD, Leventhal H. New York: Routledge;
2003:42–65.
48. Central Statistical Agency. Population Projection of Ethiopia for All Regions
At Wereda Level from 2014 – 2017. Addis Ababa; 2013.
49. Central Statistics Agency. Ethiopian Population and Housing Census Report.
Addis Ababa, 2007.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Habte et al. Journal of Pharmaceutical Policy and Practice  (2017) 10:14 Page 9 of 9
